Christus Settles Medicare Fraud Charges for Nearly $1M
Houston-based Christus Health Systems will pay the federal government nearly $971,000 to settle whistleblower allegations that several of its hospitals in Texas and Louisiana fraudulently billed Medicare for ineligible costs and expenses and failed to disclose overpayments.
The settlement by Christus, which operates more than 40 hospitals and facilities in eight states, resolves a whistleblower's lawsuit that alleged fraudulent Medicare billings as far back as 1988 while others occurred as recently as 2001. The lawsuit had been under seal until this month, when a federal district court judge in Los Angeles unsealed the case.
The hospitals involved in the settlement include St. Mary's Galveston Hospital in Galveston, Texas; St. Michael's Health System in Texarkana, Texas; Christus Hospital—St. Elizabeth in Beaumont, TX; Christus Hospital—St. Mary in Port Arthur, TX; Christus Schumpert Health System in Shreveport, LA; Christus St. Frances Cabrini Hospital in Alexandria, LA; and Christus St. John Hospital in Nassau Bay, TX.
Christus Health paid the settlement without admitting any wrongdoing.
The whistleblower lawsuit was filed in 1998 by Mark Razin, a former employee of Healthcare Financial Advisors, a California-based consulting firm that helped hospitals prepare cost reports that were submitted to Medicare/Medicaid. The lawsuit alleged that HFA helped hospitals seek reimbursement for unallowable costs and helped conceal known overpayments from the government, federal prosecutors said.
- How Top-Ranked MA Plans Earn Their Stars
- How Hospitals Can Become 'Upstreamists'
- WellPoint Dominates Nearly Half of Markets, AMA Says
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- Readmissions: No Quick Fix to Costly Hospital Challenge
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- 4 Tips for Managing Employed Physicians
- Providers Ask HHS to Address EHR Interoperability Barriers
- The Drug Price Reform Debate